SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-282293
Filing Date
2023-11-22
Accepted
2023-11-22 16:38:56
Documents
5
Group Members
ELIZABETH HOGESEVEN ONE EIGHT THREE FOUR IRREVOCABLE TRUSTSINAN KALAYOGLU

Document Format Files

Seq Description Document Type Size
1 SC 13D d503994dsc13d.htm SC 13D 132405
2 EX-99.1 d503994dex991.htm EX-99.1 4153
3 EX-99.2 d503994dex992.htm EX-99.2 3370
4 EX-99.3 d503994dex993.htm EX-99.3 2912
5 EX-99.4 d503994dex994.htm EX-99.4 2842
  Complete submission text file 0001193125-23-282293.txt   147152
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Subject) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89550 | Film No.: 231434017
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARTESIAN THERAPEUTICS, INC. 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address
Kalayoglu Murat (Filed by) CIK: 0002000002 (see all company filings)

Type: SC 13D